Journal of Psychopharmacology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

SAGETRACK

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malcolm, K.
Right arrow Articles by Peet, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Malcolm, K.
Right arrow Articles by Peet, M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Psychopharmacology, Vol. 5, No. 3, 255-258 (1991)
DOI: 10.1177/026988119100500313

Antidepressant drug treatment in relation to the use of ECT

Katy Malcolm

Lecturer in Psychiatry, Northern General Hospital

Jacinta Dean

Staff Pharmacist, Middlewood Hospital

Paul Rowlands

Registrar in Psychiatry, Northern General Hospital and Senior Lecturer in Psychiatry, Northern General Hospital, Sheffield

Malcolm Peet

Staff Pharmacist, Middlewood Hospital

The adequacy of antidepressant treatment by psychiatrists prior to ECT was examined in a group of 95 patients. ECT was considered inevitable in 16 cases. Of the remainder, 41 patients had not been given adequate antidepressant treatment prior to ECT. Alternative drug strategies were seldom pursued after one drug had failed. Most patients were continued on a variety of psychotropic drugs during ECT. Subsequent outcome was poor, which may reflect difficulty in identifying an appropriate drug for continuation treatment after ECT.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J PsychopharmacolHome page
M. Peet
Commentary on 'The management of treatment-resistant affective disorder: clinical perspectives'
J Psychopharmacol, January 1, 1992; 6(2): 160 - 161.
[PDF]